Exploring Next Generation Sequencing

Providence, Rhode Island (September 21-23, 2009)

The term "next-generation" has become the "now-generation" as sequencing platforms are thriving and driving biological discovery. As costs come down and ease increases these sequencing platforms continue to infiltrate numerous aspects of basic and biomedical research. All agree however, with the implementation of any new technology there is a balancing act of cost-quality-quantity. Each next-generation sequencing platform best lends itself to specific sequencing goals. Cambridge Healthtech Institute's Third Annual Exploring Next-Generation Sequencing offers an unparalleled opportunity to compare and contrast existing and future next-generation sequencing platforms to best suit your research needs.

Coverage Includes:

Sequencing: Past, Present, and Future  NGS Insights, Strategies and SolutionsNext-Next Generation SequencingSequencing ApplicationsCase StudiesPre-Conference Workshop:

DATA MANAGEMENT AND STORAGE: THE NEXT HURDLE FOR NGS*

Chris Dagdigian, Founding Partner and Director of Technology, BioTeam, Inc.Jacob Farmer, Chief Technology Officer, Cambridge Computer

Sequencing Tech Expo:

Next-Generation Sequencing is alive, thriving, and driving discovery. As costs come down and ease increases, these new massively parallel high-throughput sequencing platforms are infi ltrating multiple aspects of traditional biological research. However, each next-generation sequencing platform best lends itself to specific sequencing goals. This Tech Expo showcases the next-generation sequencing platforms to help you make informed purchasing decisions.

More: http://www.healthtech.com/sqe?c=6911